Defective Breast Mesh, Acellular Dermal Matrix, and Bioabsorbable Scaffold Injury Attorneys in Colorado: The Complete Guide for Women, Families, and Survivors
For many women in Colorado, the journey through breast reconstruction or augmentation is paved with a desire for healing, restoration, or confidence. Whether you walked through the doors of a premier NCI-Designated Comprehensive Cancer Center in the Denver Metro area or sought out a high-volume aesthetic practice in the heart of the Rockies, you placed your trust in medical technology designed to support your recovery. However, thousands of women across the country—and right here in Colorado—are discovering that the surgical mesh, acellular dermal matrix (ADM), or bioabsorbable scaffolds used in their bodies were never specifically cleared or approved by the FDA for breast surgery.
At The Manginello Law Firm, PLLC, known to the community as Attorney911, we recognize the profound betrayal felt when a medical device meant to provide support instead leads to catastrophic infection, reconstruction failure, or even a cancer diagnosis like BIA-ALCL or BIA-SCC. For twenty-seven years, Managing Partner Ralph Manginello has stood as a shield for those exploited by institutional negligence. With our deep roots in high-profile litigation—including our current leadership in cases seeking $10,000,000 in damages like Bermudez v. Pi Kappa Phi—we bring a level of aggressive, federal-court authority that generalist firms simply cannot match. If your body is reacting to a device you never asked for, or if you feel your surgeon in Colorado failed to provide adequate informed consent regarding “off-label” products, we are here to provide the clinical and legal clarity you deserve.
Understanding the “Internal Bra” and the Devices Left in Your Body
In the specialized orthopedic and reconstructive landscape of Colorado, many surgeons employ what is colloquially known as the “internal bra” technique. This involves using a material to support the lower pole of the breast, much like a sling, to manage the weight of an implant or to provide a scaffold for tissue growth.
These products generally fall into three categories:
- Acellular Dermal Matrix (ADM): Biologic grafts derived from human or animal skin that has been “decellularized” to leave behind a collagen scaffold. Common brands include AlloDerm (AbbVie), Strattice, FlexHD (MTF Biologics), and AlloMax (Becton Dickinson).
- Bioabsorbable Scaffolds: Synthetic materials designed to be slowly resorbed by the body over 12 to 24 months. These are often made of poly-4-hydroxybutyrate (P4HB). The most controversial of these is GalaFLEX (manufactured by Tepha/Galatea and owned by BD) and Phasix.
- Synthetic Mesh: Permanent plastics like polypropylene that were originally designed for hernia repair but have been used off-label in breast surgery.
What many patients in Denver, Boulder, and Colorado Springs are never told is that no surgical mesh products have been cleared or approved by the FDA for use in breast surgery. This startling reality was underscored in the FDA’s November 9, 2023, letter to health care providers, which explicitly warned that the safety and effectiveness of these devices in the breast have not been determined.
The Regulatory Failure: The 510(k) “Predicate Creep”
The legal spine of a defective device case in Colorado often centers on how these products reached the market. Most of these scaffolds did not undergo the rigorous Premarket Approval (PMA) process required for Class III high-risk devices. Instead, they utilized the 510(k) clearance pathway—a regulatory shortcut that only requires a manufacturer to show their device is “substantially equivalent” to a predicate device already on the market.
This has led to a phenomenon known as “predicate creep.” For example, the manufacturers of GalaFLEX cited a surgical suture as a predicate device. A suture is used for wound closure; a mesh is used for structural reinforcement over a large surface area. By claiming these two vastly different uses are “equivalent,” materials that were never clinically tested in breast tissue—where the presence of breast cancer or irradiated tissue significantly changes the healing environment—ended up in operating rooms across Colorado.
Our firm understands the nuance of Medtronic v. Lohr, 518 U.S. 470 (1996), which confirms that 510(k) clearance does not preempt state-law claims. Unlike PMA devices protected under Riegel v. Medtronic, these 510(k) products are subject to the full weight of Colorado product liability law. Ralph Manginello and Lupe Peña use this doctrinal advantage to hold manufacturers like Becton Dickinson and AbbVie accountable for what we believe is an intentional bypass of patient safety in favor of market dominance.
Verbatim FDA Warnings Colorado Patients Must See
The FDA has been increasingly vocal about the risks associated with ADM and scaffolds. If you are a survivor or a surgery patient, these words should be front and center in your medical timeline:
“The safety and effectiveness of surgical mesh in breast surgery, including in augmentation or reconstruction, has not been determined by the FDA.” — FDA Letter to Health Care Providers, November 9, 2023.
The agency specifically identified GalaFLEX Scaffold, GalaFLEX 3D, Phasix Mesh, and Phasix ST in this category. Furthermore, in an earlier March 2021 communication, the FDA named FlexHD and AlloMax as having “significantly higher” complication rates—including reoperation and infection—than other ADMs.
If your surgeon in Colorado used these specific brands and you are now experiencing pain or deformity, you may be the victim of a device with a documented record of failure. We invite you to call us at 1-888-ATTY-911 for a confidential, no-obligation conversation. We have dedicated decades to these complex intersections of medicine and law.
The Complication Spectrum: More Than Just a “Slow Recovery”
Many women in the Denver area are told their redness or swelling is just a “typical” part of the healing process. However, the peer-reviewed evidence tells a different story. At Attorney911, we represent clients facing the full spectrum of mesh-related trauma:
Red Breast Syndrome and Endotoxin Science
Red Breast Syndrome is a sterile inflammatory reaction specific to Acellular Dermal Matrix. Recent science suggests this is caused by “endotoxin”—remnants of bacterial cell walls that survive the sterilization process. While the bacteria are dead, the toxins remain biologically active, triggering a persistent, bright red rash on the breast that often leads to unnecessary antibiotic treatments.
BIA-ALCL: The Cancer Link
Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) is a T-cell lymphoma that develops in the scar tissue (capsule) around textured implants. The FDA requested a worldwide recall of Allergan BIOCELL textured implants in July 2019 due to this risk. If you have textured implants and notice a late-onset swelling (seroma) or a mass years after your surgery, this is a medical emergency that requires immediate biopsy.
BIA-SCC: Emerging Epithelial Tumors
A newer, equally concerning diagnosis is Breast Implant-Associated Squamous Cell Carcinoma (BIA-SCC). Reported latency for this cancer ranges from seven to over forty years post-implantation. Unlike ALCL, this epithelial tumor has been found in both textured and smooth implants.
Bioabsorbable Scaffold Failure-to-Resorb
Products like GalaFLEX are marketed to disappear within 18 to 24 months. Yet, our firm has seen records through the MAUDE adverse event database indicating these scaffolds can remain palpable, rigid, and painful years after they should have resorbed. This can lead to “bottoming out” or permanent contour deformities that require multiple revision surgeries to correct.
Colorado Statutes of Limitation and the Discovery Rule
Timing is the most critical element of your legal journey. In Colorado, the statute of limitations for a product liability action is generally two years from the date the injury is discovered or reasonably should have been discovered.
Because many of these devices fail years after implantation—and because the FDA only recently issued its strongest warnings in late 2023—the “discovery rule” is your lifeline. A woman in Colorado who had surgery five years ago but only learned of the mesh-link after a 2024 revision surgery may still have a valid claim. Our firm, including Associate Attorney Lupe Peña, who is licensed by the State Bar of Texas and admitted to federal courts, understands how to navigate these deadlines to ensure your right to compensation is protected.
The Whistleblower: Dr. Hooman Noorchashm’s Allegations
The case against Becton Dickinson (BD) is significantly bolstered by the testimony of Dr. Hooman Noorchashm. A cardiothoracic surgeon and former BD Medical Director, Dr. Noorchashm was terminated in 2022 after raising internal alarms. He alleges that BD withheld data regarding breast cancer recurrences in its GalaFLEX clinical trials and engaged in rampant off-label marketing without FDA authorization.
When you hire Attorney911, you are hiring a firm that monitors these high-level investigative records. We don’t just look at your medical files; we look at the internal corporate failures that allowed these devices to enter the Colorado market in the first place.
Why Attorney911 for Your Colorado Device Case?
We recognize that you have choices when it comes to legal representation. However, defective device litigation is not the same as a standard personal injury case. It requires a firm that operates at a federal level and understands the “defense playbook.”
- Federal Court Authority: Ralph Manginello is admitted to the United States District Court for the Southern District of Texas and handles cases with national implications. Our experience in complex, multi-defendant institutional liability—proven by our current work in Bermudez v. Pi Kappa Phi—means we are not intimidated by the billion-dollar legal teams representing medical manufacturers.
- A Bilingual Advantage: Lupe Peña provides full consultations in fluent Spanish (hablamos español). We believe that your access to justice in Colorado should not be gated by a language barrier. Direct attorney-client communication is a core firm asset.
- Verified Excellence: With a 4.9 out of 5.0 rating across hundreds of Birdeye reviews and an 8.2 “Excellent” Avvo rating, our reputation is built on the word of our clients. We are members of the Pro Bono College of the State Bar of Texas, requiring 75+ hours of annual service—a testament to our commitment to people over profit.
- The Insurance Insider Perspective: Lupe Peña’s background in insurance defense gives our firm an “insider” view of how carriers attempt to devalue your claim. We know how they calculate pain and suffering and how they use “learned intermediary” defenses to shift blame to your surgeon. We are three steps ahead of them.
Frequently Asked Questions for Colorado Patients
Is surgical mesh approved for use in my breast reconstruction?
No. While many devices are cleared through the 510(k) process for general tissue reinforcement, the FDA has explicitly stated that they have not determined the safety or effectiveness of these products specifically for breast surgery.
What if I don’t know which brand of mesh was used?
This is common. We can help you request your full operative reports and implant documentation cards from your hospital in Colorado. These records should contain “implant stickers” with the Unique Device Identifier (UDI) and lot numbers.
My surgeon said GalaFLEX was “dissolvable” and safe. Do I still have a case?
Yes. If the manufacturer marketed the device to your surgeon for off-label use without disclosing the elevated risks of infection or cancer recurrence, the manufacturer may be liable for “failure to warn.”
What is the cost of an initial consultation?
There is zero upfront cost. We work on a contingency-fee basis, meaning we only recover if you do. You can call 1-888-ATTY-911 for a free, confidential strategy session.
Can I sue if I have “Breast Implant Illness”?
Breast Implant Illness (BII) involves a constellation of systemic symptoms like fatigue, joint pain, and brain fog. While the FDA is currently studying BII, we look at these cases through the lens of failure to warn and the immunological response to the device surface and materials.
Taking Your Next Steps in Colorado
If you are a breast cancer survivor who just found out your reconstruction is failing, or a prophylactic mastectomy patient facing permanent disfigurement, the road back to health can feel lonely. But in the legal field, you have a powerful ally.
At The Manginello Law Firm, PLLC, we treat every case as a mission. We are not a settlement mill; we are a trial firm. We are the attorneys who took on the University of Houston and national fraternities when no one else would. We bring that same “never settle for less” energy to the women of Colorado.
Whether you need a second opinion on your legal options or you are ready to file a complaint against a manufacturer that put profits over your pathology, we are here. Honor your experience by taking action.
Contact Attorney911 today. Call 1-888-ATTY-911 (1-888-288-9911). Let us look at your records, examine the regulatory history of the device used in your body, and fight for the recovery you were promised.
Note: Ralph P. Manginello is licensed in Texas (Bar #24007597) and admitted to the Southern District of Texas. Lupe Peña is licensed in Texas (Bar #24084332). For cases outside of Texas, the firm may associate with local counsel or seek admission pro hac vice as required by law. Past results do not guarantee future outcomes. This content is for educational purposes and does not constitute medical or legal advice.
